SRTA
Strata Critical Medical Stock Analysis
AI Rating
- Quality3/10
- Growth↑ 9/10
- Value↑ 8/10
SRTA Growth
- Revenue Y/Y↑ 34.28%
- EPS Y/Y↑ 242.86%
- FCF Y/Y↓ -68.80%
SRTA Profitability
- Gross margin ↑ 20.90%
- EPS margin↑ 21.00%
- ROIC 5Y↑ -13.08%
SRTA Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↑ 999.0
Strata Critical Medical stock volatility is higher than the overall market. We give it a Great risk rating.